AMCo comes again for a bolt-on levloan
Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has laid out price guidance for a €163.7m leveraged loan that will fund a bolt-on acquisition.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts